Sandra E. Fischer
1 King's College Circle
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
GATA6 immunohistochemistry and prognosis after surgical resection of pancreatic adenocarcinoma: results from the ESPAC-4 trial.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 24, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 10, 2025
Plasma Cell-free DNA Methylomes for Hepatocellular Carcinoma Detection and Monitoring After Liver Resection or Transplantation.
Journal: Annals of surgery
Published: May 22, 2025
Qualitative and quantitative assessment of gadoxetic acid MRI in distinguishing atypical focal nodular hyperplasia from hepatocellular adenoma subtypes.
Journal: European radiology
Published: January 11, 2025
Evolutionary dynamics of recurrent hepatocellular carcinoma under divergent immune selection pressures.
Journal: Frontiers in oncology
Published: November 29, 2024
Non-invasive liver fibrosis screening on CT images using radiomics.
Journal: BMC medical imaging
Published: November 29, 2024
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.
Journal: Nature communications
Published: November 20, 2024
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.
Journal: NPJ precision oncology
Published: August 04, 2024
Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters.
Journal: Microbiome
Published: April 08, 2024
Assessing clinical and metabolic responses related to hyperlipidemia, MASLD and type 2 diabetes: sleeve versus RYGB.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: April 03, 2024
Last Updated: 09/26/2026